Miron Richard J, Moraschini Vittorio, Fujioka-Kobayashi Masako, Zhang Yufeng, Kawase Tomoyuki, Cosgarea Raluca, Jepsen Soren, Bishara Mark, Canullo Luigi, Shirakata Yoshinori, Gruber Reinhard, Ferenc Döri, Calasans-Maia Monica Diuana, Wang Hom-Lay, Sculean Anton
Department of Periodontology, University of Bern, Bern, Switzerland.
Department of Periodontology, Dental Research Division, School of Dentistry, Veiga de Almeida University, Rio de Janeiro, Brazil.
Clin Oral Investig. 2021 May;25(5):2461-2478. doi: 10.1007/s00784-021-03825-8. Epub 2021 Feb 20.
This study aims to compare the treatment outcomes of periodontal intrabony defects by using platelet-rich fibrin (PRF) with other commonly utilized modalities.
The eligibility criteria comprised randomized controlled trials (RCTs) comparing the clinical outcomes of PRF with that of other modalities. Studies were classified into 10 categories as follows: (1) open flap debridement (OFD) alone versus OFD/PRF; (2) OFD/bone graft (OFD/BG) versus OFD/PRF; (3) OFD/BG versus OFD/BG/PRF; (4-6) OFD/barrier membrane (BM), OFD/PRP, or OFD/enamel matrix derivative (EMD) versus OFD/PRF; (7) OFD/EMD versus OFD/EMD/PRF; (8-10) OFD/PRF versus OFD/PRF/metformin, OFD/PRF/bisphosphonates, or OFD/PRF/statins. Weighted means and forest plots were calculated for probing depth (PD), clinical attachment level (CAL), and radiographic bone fill (RBF).
From 551 articles identified, 27 RCTs were included. The use of OFD/PRF statistically significantly reduced PD and improved CAL and RBF when compared to OFD. No clinically significant differences were reported when OFD/BG was compared to OFD/PRF. The addition of PRF to OFD/BG led to significant improvements in CAL and RBF. No differences were reported between any of the following groups (OFD/BM, OFD/PRP, and OFD/EMD) when compared to OFD/PRF. No improvements were also reported when PRF was added to OFD/EMD. The addition of all three of the following biomolecules (metformin, bisphosphonates, and statins) to OFD/PRF led to statistically significant improvements of PD, CAL, and RBF.
The use of PRF significantly improved clinical outcomes in intrabony defects when compared to OFD alone with similar levels being observed between OFD/BG and OFD/PRF. Future research geared toward better understanding potential ways to enhance the regenerative properties of PRF with various small biomolecules may prove valuable for future clinical applications. Future research investigating PRF at histological level is also needed.
The use of PRF in conjunction with OFD statistically significantly improved PD, CAL, and RBF values, yielding to comparable outcomes to OFD/BG. The combination of PRF with bone grafts or small biomolecules may offer certain clinical advantages, thus warranting further investigations.
本研究旨在比较富血小板纤维蛋白(PRF)与其他常用方法治疗牙周骨内缺损的疗效。
纳入标准为比较PRF与其他方法临床疗效的随机对照试验(RCT)。研究分为以下10类:(1)单纯开放性翻瓣清创术(OFD)与OFD/PRF;(2)OFD/骨移植(OFD/BG)与OFD/PRF;(3)OFD/BG与OFD/BG/PRF;(4 - 6)OFD/屏障膜(BM)、OFD/富血小板血浆(PRP)或OFD/釉基质衍生物(EMD)与OFD/PRF;(7)OFD/EMD与OFD/EMD/PRF;(8 - 10)OFD/PRF与OFD/PRF/二甲双胍、OFD/PRF/双膦酸盐或OFD/PRF/他汀类药物。计算探诊深度(PD)、临床附着水平(CAL)和影像学骨填充(RBF)的加权均值并绘制森林图。
在检索到的551篇文章中,纳入了27项RCT。与单纯OFD相比,使用OFD/PRF在统计学上显著降低了PD,改善了CAL和RBF。OFD/BG与OFD/PRF相比,未报告有临床显著差异。在OFD/BG基础上加用PRF可显著改善CAL和RBF。与OFD/PRF相比,以下任何一组(OFD/BM、OFD/PRP和OFD/EMD)之间均未报告有差异。在OFD/EMD基础上加用PRF也未报告有改善。在OFD/PRF基础上加用以下三种生物分子(二甲双胍、双膦酸盐和他汀类药物)均在统计学上显著改善了PD、CAL和RBF。
与单纯OFD相比,PRF的使用显著改善了骨内缺损的临床疗效,OFD/BG与OFD/PRF之间观察到相似水平。未来旨在更好地理解用各种小生物分子增强PRF再生特性的潜在方法的研究,可能对未来临床应用具有重要价值。还需要在组织学水平研究PRF的未来研究。
OFD联合使用PRF在统计学上显著改善了PD、CAL和RBF值,产生了与OFD/BG相当的结果。PRF与骨移植或小生物分子的联合可能具有一定的临床优势,因此值得进一步研究。